Mike Durkin

Regional Director, Medical Science Liaisons at Blueprint Medicines
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Philadelphia

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 1 ratings
  • (1)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Mike Brooks

Mike has a very strong understanding of all aspects of pharmaceutical customer communication. Mike's diversified background gives him a rare understanding of customer needs. Mike is also gifted with an extraordinary ability to read, digest, and retain medical data. He can take very technical information to anyone's level, from national researcher to a new hire in sales. Mike's is considered by all who have worked with him to be one of the best oncology data sources in the business. In addition to all of this, he is a great team member and makes work more enjoyable for those around him.

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 400 - 500 Employee
    • Regional Director, Medical Science Liaisons
      • Mar 2020 - Present

    • Medical Science Liaison
      • Oct 2019 - Present

    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Regional Director
      • Feb 2019 - Oct 2019

    • Sr Medical Science Liaison
      • Oct 2018 - Feb 2019

    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Senior Medical Science Liaison
      • Aug 2014 - Sep 2018

    • Chemical Manufacturing
    • 700 & Above Employee
    • Medical Science Liaison
      • Apr 2014 - Aug 2014

      MSL supporting radium 223 and Bayer pipeline products MSL supporting radium 223 and Bayer pipeline products

    • Norway
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Medical Science Liaison
      • Apr 2013 - Aug 2014

      MSL supporting radium 223 MSL supporting radium 223

    • France
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Director, Oncology Field Medical Training
      • Aug 2012 - Apr 2013

    • Medical Science Liaison
      • May 2010 - Aug 2012

    • District Sales Manager
      • Feb 2007 - Jun 2010

      Responsible for 12 Oncology Sales Professionals who promote Taxotere (docetaxel) or Eloxatin (oxaliplatin) in the Philadelphia and Southern New Jersey region

    • regional sales trainer
      • Jul 2006 - Jan 2007

      trained new oncology sales professionals on disease state, product and market competitors. worked with marketing on training initiatives for new sales materials and POA meetings

    • Oncology Sales Executive
      • Dec 2002 - Jun 2006

      Oncology sales professional repsonsible for presentations to healthcare professionals about the labeled indications for Taxotere (docetaxel).

    • Territory Manager, Clinical Liaison
      • Aug 1997 - Dec 2002

      Small biotech company, developed a novel class of pro-apoptic agents. Also promoted commercial compounds such as Nilandron and Gelclair. Financial pressures led to the company being aquired by OSI Pharmaceuticals in 2003. Small biotech company, developed a novel class of pro-apoptic agents. Also promoted commercial compounds such as Nilandron and Gelclair. Financial pressures led to the company being aquired by OSI Pharmaceuticals in 2003.

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Staff Oncology Nurse
      • May 1994 - Aug 1997

Education

  • Rutgers University - Camden
    BSN, Nursing
    1988 - 1994

Community

You need to have a working account to view this content. Click here to join now